No one wants to see a bunch of people be treated with something that causes an unexpected serious adverse reaction. Have to start slow and prove the safety.
Ann: Initial Dosing Completed in Cohort 1 of RP11 MAD Study, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $330.8K | 3.030M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 531247 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 128281 | 3 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |